These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6897588)

  • 1. A platelet aggregating substance contained in xanthine oxidase preparation from cow's milk.
    Ishii H; Hiraishi S; Kazama M
    Thromb Res; 1982 Oct; 28(1):85-92. PubMed ID: 6897588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superoxide-independent platelet response to xanthine oxidase.
    Patscheke H; Paschen W; Wörner P
    Hoppe Seylers Z Physiol Chem; 1978 Aug; 359(8):933-7. PubMed ID: 213366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superoxide, xanthine oxidase and platelet reactions: further studies on mechanisms by which oxidants influence platelets.
    Levine PH; Sladdin DG; Krinsky NI
    Thromb Haemost; 1981 Jun; 45(3):290-3. PubMed ID: 6269249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binding of bovine platelet aggregating factor to human platelets.
    Brown JE; Thuy LP
    Thromb Res; 1981 Apr 1-15; 22(1-2):41-51. PubMed ID: 7292446
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet activation by platelet aggregation factor from Eisenia foelide.
    Qian R; Zhou YC; Zhuang QQ
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):432-5. PubMed ID: 7717070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unsaturated platelet-activating factor: influence on aggregation, serotonin release and thromboxane synthesis of human thrombocytes.
    Korth R; Riess H; Brehm G; Hiller E
    Thromb Res; 1986 Mar; 41(5):699-706. PubMed ID: 3961742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of platelet function by superoxide anion.
    Handin RI; Karabin R; Boxer GJ
    J Clin Invest; 1977 May; 59(5):959-65. PubMed ID: 192766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prostaglandin E1 on platelet attenuation of oxidant-induced edema in isolated rabbit lungs.
    Heffner JE; Baron DA
    J Lab Clin Med; 1990 Dec; 116(6):797-804. PubMed ID: 2246556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new platelet aggregating material (PAM) in an experimentally induced rat fibrosarcoma.
    Mohanty D; Hilgard P
    Thromb Haemost; 1984 Apr; 51(2):192-5. PubMed ID: 6740552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Purification and some properties of platelet aggregating protein (PAP) from the plasma of a patient with thrombotic thrombocytopenic purpura].
    Chen SH
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):382-4, 28. PubMed ID: 2598093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet aggregation with glyceryl trinitrate and xanthine oxidoreductase.
    O'Byrne S; Shirodaria C; Millar T; Stevens C; Blake D; Benjamin N
    J Pharmacol Exp Ther; 2000 Jan; 292(1):326-30. PubMed ID: 10604966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of platelet aggregating activity from tumor cells: copurification with procoagulant activity.
    Cavanaugh PG; Sloane BF; Bajkowski AS; Taylor JD; Honn KV
    Thromb Res; 1985 Jan; 37(2):309-26. PubMed ID: 3975874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The released proteins from avian thrombocytes.
    Wachowicz B; Krajewski T
    Thromb Haemost; 1979 Dec; 42(4):1289-95. PubMed ID: 542934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma aggregating factor (bovine) for human platelets: a marker for study of antihemophilic and von Willebrand Factors.
    Griggs TR; Cooper HA; Webster WP; Wagner RH; Brinkhous KM
    Proc Natl Acad Sci U S A; 1973 Oct; 70(10):2814-8. PubMed ID: 4542779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor.
    Ostermann G; Till U; Thielmann K
    Thromb Res; 1983 Apr; 30(2):127-36. PubMed ID: 6408754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet responses to platelet-activating factor are inhibited in alcoholics undergoing alcohol withdrawal.
    Neiman J; Rand ML; Jakowec DM; Packham MA
    Thromb Res; 1989 Nov; 56(3):399-405. PubMed ID: 2617478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Res; 1999 Sep; 95(6):315-23. PubMed ID: 10527409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a potent platelet aggregation inhibitor from Agkistrodon rhodostoma snake venom.
    Huang TF; Wu YJ; Ouyang C
    Biochim Biophys Acta; 1987 Sep; 925(3):248-57. PubMed ID: 3620499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a polyoxyethylene detergent (Brij 58) on platelet aggregation, release and clotting activity.
    Barton PG
    Biochim Biophys Acta; 1978 Feb; 539(1):98-113. PubMed ID: 623796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.